Just In
- 1 hr ago Thrissur Pooram 2024: Date, Time, History, Significance, And Celebrations Related To Kerala's Rich Traditions
- 5 hrs ago Daily Horoscope, 19 April 2024: Gemini Will Have A Controversial Day In Terms Of Love
- 8 hrs ago Kamada Ekadashi 2024 Wishes: Greetings, Messages, Texts, Images, Twitter Status And Instagram Captions
- 9 hrs ago Deepika Padukone's 6 Refreshing Skincare Tips to Beat the Summer Heat
Don't Miss
- Technology TSMC's Global Expansion Could Drive Up Chip Costs, Making Tech More Expensive
- Automobiles Suzuki Motorcycle India Achieves Production of Over 8 Million Two-Wheelers
- Movies LSD 2 Review: Dibakar Banerjee Presents An Entertaining And Relatable Love S*X Aur Dhokha
- Finance Iran-Israel War: How It Impacts Nifty, Sensex And Indian Rupee
- News Lok Sabha Election 2024: Polling Begins In 39 Lok Sabha Seats In Tamil Nadu
- Sports IPL 2024: 'It was his idea only' - Rinku Singh reveals Gautam Gambhir's masterstroke with Sunil Narine move
- Education Karnataka SSLC Result 2024 Soon, Know How to Check Through Website, SMS and Digilocker
- Travel Telangana's Waterfall: A Serene Escape Into Nature's Marvels
India-Made Covaxin Now On UK's Approved Travel List
India's indigenously-made 'Covaxin', one of the vaccines being used nationwide in the inoculation campaign against the COVID-19 pandemic, is on the UK's list of approved COVID-19 vaccines for international travellers from Monday, November 22.
It will benefit more fully vaccinated Indians planning travel to the UK without the need for a pre-departure PCR test or self-isolation at the address declared on their compulsory Passenger Locator Forms.
Like other fully vaccinated travellers, including those vaccinated with Covishield, they are required to pre-book a PCR or Lateral Flow Test on arrival in England, to be taken before the end of day 2.
"From 4 am on Monday 22 November, the government will recognise vaccines on the World Health Organisation's Emergency Use Listing (WHO EUL) at the border," the UK's Department for Transport (DfT) confirmed.
"As a result, Sinovac, Sinopharm Beijing and Covaxin will be added to our existing list of approved vaccines for inbound travel, benefitting more fully vaccinated passengers," it said.
Earlier this month, the Bharat Biotech manufactured Covaxin - the second most used formulation in India - had received its WHO EUL status, resulting in the UK announced plans to include it on its list of approved Covid vaccines from November 22.
The WHO Emergency Use Listing process includes a review of the quality, safety and efficacy data performed by WHO experts and many countries such as the United States, Spain, Sweden, Switzerland and Iceland recognise this categorisation.
Meanwhile, travellers who aren't fully vaccinated against COVID-19 are required to undergo a pre-departure test and 10-day quarantine at a declared address in Britain.
From Monday, the UK government said it is also simplifying travel rules for all under-18s coming to England from a non-red-list country, who will be treated as fully vaccinated at the border, regardless of their individual vaccination status. This means they will be exempt from self-isolation requirements on arrival and will only be required to take a lateral flow test post-arrival, with a free confirmatory PCR test if they test positive.
While public health is a devolved matter, the government said it is working closely with the devolved administrations of Wales, Scotland and Northern Ireland to ensure a UK-wide approach to the rules.
- healthCOVID-19 Vaccines and Heart Attacks: New Studies Show Different Results; What Are They?
- wellnessCorbevax Will Be Allowed As A Booster For Those Fully Vaccinated With Covishield Or Covaxin
- kidsCovid-19 Vaccines For Kids: DCGI Grants Emergency Use Nod To 3 Vaccines For Different Age Group Of Children
- wellnessBooster Dose Of COVID Vaccine Needed To Fight Against Omicron: Study
- wellnessIndia's Covaxin To Be Evaluated As COVID-19 Vaccine Candidate In USA
- healthCovaxin Granted Emergency Use Listing In 13 Nations As On Jan 31 According To WHO: Government
- healthEach Dose Of Covishield, Covaxin Likely To Be Capped At Rs 275 After Getting Regular Market Approval
- healthMedia Reports Stating Vaccine Shortage In Maharashtra Are Not Factually Correct: Govt
- healthGovt's Decision On COVID-19 Vaccination For Children 'Unscientific': Senior AIIMS Epidemiologist
- healthCovaxin's Shelf Life Extended To 12 Months From Date Of Manufacture
- healthExperts Allay Covaxin Concerns, Say 50% Effectiveness Against Delta-Driven COVID-19 Surge Not Bad
- healthGovernment Nod To Commercial Export Of Covishield, Covaxin In View Of Sufficient Stock